But I also see it as an economic & political blunder — the world could have had a malaria vaccine sooner. We should learn from this, not just celebrate & move on. That's what this 9000 word essay is about. worksinprogress.co/issue/why-we-d…
The malaria vaccine was trialled for the first time in humans in 1997.
It was approved in 2021.
Each step of the journey faced struggles in funding and operations, to set up & run each next stage of trials.
In 2015, after the vaccine went through all prelicensure stages of clinical trials, the WHO asked for pilot projects to rule out potential side effects, that were based on post-hoc analyses of the trial data.
It then took another 4 years just to *start the pilot project.*
In sum, the RTS,S malaria vaccine spent 23 years in 25 trials and pilot studies, before it was licensed.
We could have had a malaria vaccine sooner, and we should have.
This isn't the typical narrative we hear about new discoveries and technologies. And that's why the story needs to be more widely known. worksinprogress.co/issue/why-we-d…
Not every pathogen we'll face will have such a complex lifecycle.
But the overarching problem – the lack of funding to develop vaccines for the global poor – will remain.
💡 Direct testing for flu is very limited in many countries. This does not show the total number of flu infections in the country. ourworldindata.org/explorers/infl…
• How many people die from flu each year?
• How has mortality changed over time?
• Which strains are currently circulating?
• What can flu-like illness trackers tell us?
Children inherit chromosomes from each parent, but those had gone through recombination and have a mix of segments from their parents (the child's grandparent).
Siblings inherit some of the same segments and some different.
Some nice posts by @Graham_Coop on this topic. From them I also learnt that recombination rates are different in males and females.